Andson Biotech
Empowering Mass Spec for Biotech and Beyond
About Andson Biotech
Empowering Mass Spec for Biotech and Beyond
Company details
Funding
Total raised
$8.7M
Last stage
Series A
Investors
Founders
Mason Chilmonczyk
Mason is the co-founder and CEO of Andson Biotech, an academic spinout based on Mason's research at the Georgia Institute of Technology. At Andson, Mason is driving the company's mission to develop novel methodologies for advanced biomanufacturing discovery and monitoring. Mason is formally trained as a mechanical engineer with a BS from the University of South Florida ('14) and an MS and PhD from Georgia Tech ('17, '20).
LinkedInAndrei Fedorov
Professor who co-founded Andson Biotech with expertise in biotools for mass spectrometry sample prep and analytics.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.